441 related articles for article (PubMed ID: 10397798)
1. Peptides and proteins in neurodegenerative disease: helix propensity of a polypeptide containing helix 1 of the mouse prion protein studied by NMR and CD spectroscopy.
Liu A; Riek R; Zahn R; Hornemann S; Glockshuber R; Wüthrich K
Biopolymers; 1999; 51(2):145-52. PubMed ID: 10397798
[TBL] [Abstract][Full Text] [Related]
2. NMR structure of the mouse prion protein domain PrP(121-231).
Riek R; Hornemann S; Wider G; Billeter M; Glockshuber R; Wüthrich K
Nature; 1996 Jul; 382(6587):180-2. PubMed ID: 8700211
[TBL] [Abstract][Full Text] [Related]
3. The key-role of tyrosine 155 in the mechanism of prion transconformation as highlighted by a study of sheep mutant peptides.
Bertho G; Bouvier G; Hoa GH; Girault JP
Peptides; 2008 Jul; 29(7):1073-84. PubMed ID: 18455265
[TBL] [Abstract][Full Text] [Related]
4. Influence of amino acid substitutions related to inherited human prion diseases on the thermodynamic stability of the cellular prion protein.
Liemann S; Glockshuber R
Biochemistry; 1999 Mar; 38(11):3258-67. PubMed ID: 10079068
[TBL] [Abstract][Full Text] [Related]
5. Spectroscopic characterization of conformational differences between PrPC and PrPSc: an alpha-helix to beta-sheet transition.
Baldwin MA; Pan KM; Nguyen J; Huang Z; Groth D; Serban A; Gasset M; Mehlhorn I; Fletterick RJ; Cohen FE
Philos Trans R Soc Lond B Biol Sci; 1994 Mar; 343(1306):435-41. PubMed ID: 7913763
[TBL] [Abstract][Full Text] [Related]
6. Clustered negative charges on the lipid membrane surface induce beta-sheet formation of prion protein fragment 106-126.
Miura T; Yoda M; Takaku N; Hirose T; Takeuchi H
Biochemistry; 2007 Oct; 46(41):11589-97. PubMed ID: 17887730
[TBL] [Abstract][Full Text] [Related]
7. Autonomous and reversible folding of a soluble amino-terminally truncated segment of the mouse prion protein.
Hornemann S; Glockshuber R
J Mol Biol; 1996 Sep; 261(5):614-9. PubMed ID: 8800210
[TBL] [Abstract][Full Text] [Related]
8. Spontaneous deamidation and isomerization of Asn108 in prion peptide 106-126 and in full-length prion protein.
Sandmeier E; Hunziker P; Kunz B; Sack R; Christen P
Biochem Biophys Res Commun; 1999 Aug; 261(3):578-83. PubMed ID: 10441469
[TBL] [Abstract][Full Text] [Related]
9. Solution structure of Syrian hamster prion protein rPrP(90-231).
Liu H; Farr-Jones S; Ulyanov NB; Llinas M; Marqusee S; Groth D; Cohen FE; Prusiner SB; James TL
Biochemistry; 1999 Apr; 38(17):5362-77. PubMed ID: 10220323
[TBL] [Abstract][Full Text] [Related]
10. Transmissible spongiform encephalopathies.
Liemann S; Glockshuber R
Biochem Biophys Res Commun; 1998 Sep; 250(2):187-93. PubMed ID: 9753605
[TBL] [Abstract][Full Text] [Related]
11. Expansion of the octarepeat domain alters the misfolding pathway but not the folding pathway of the prion protein.
Leliveld SR; Stitz L; Korth C
Biochemistry; 2008 Jun; 47(23):6267-78. PubMed ID: 18473442
[TBL] [Abstract][Full Text] [Related]
12. Prion (PrPSc)-specific epitope defined by a monoclonal antibody.
Korth C; Stierli B; Streit P; Moser M; Schaller O; Fischer R; Schulz-Schaeffer W; Kretzschmar H; Raeber A; Braun U; Ehrensperger F; Hornemann S; Glockshuber R; Riek R; Billeter M; Wüthrich K; Oesch B
Nature; 1997 Nov; 390(6655):74-7. PubMed ID: 9363892
[TBL] [Abstract][Full Text] [Related]
13. Structural insights into the interaction between prion protein and nucleic acid.
Lima LM; Cordeiro Y; Tinoco LW; Marques AF; Oliveira CL; Sampath S; Kodali R; Choi G; Foguel D; Torriani I; Caughey B; Silva JL
Biochemistry; 2006 Aug; 45(30):9180-7. PubMed ID: 16866364
[TBL] [Abstract][Full Text] [Related]
14. Unraveling the details of prion (con)formation(s): recent advances by mass spectrometry.
Principe S; Maras B; Schininà ME; Pocchiari M; Cardone F
Curr Opin Drug Discov Devel; 2008 Sep; 11(5):697-707. PubMed ID: 18729021
[TBL] [Abstract][Full Text] [Related]
15. Familial prion disease mutation alters the secondary structure of recombinant mouse prion protein: implications for the mechanism of prion formation.
Cappai R; Stewart L; Jobling MF; Thyer JM; White AR; Beyreuther K; Collins SJ; Masters CL; Barrow CJ
Biochemistry; 1999 Mar; 38(11):3280-4. PubMed ID: 10079070
[TBL] [Abstract][Full Text] [Related]
16. Preventing misfolding of the prion protein by trimethylamine N-oxide.
Bennion BJ; DeMarco ML; Daggett V
Biochemistry; 2004 Oct; 43(41):12955-63. PubMed ID: 15476389
[TBL] [Abstract][Full Text] [Related]
17. Dynamic simulation of the mouse prion protein.
Guilbert C; Ricard F; Smith JC
Biopolymers; 2000 Nov; 54(6):406-15. PubMed ID: 10951327
[TBL] [Abstract][Full Text] [Related]
18. Two-rung model of a left-handed beta-helix for prions explains species barrier and strain variation in transmissible spongiform encephalopathies.
Langedijk JP; Fuentes G; Boshuizen R; Bonvin AM
J Mol Biol; 2006 Jul; 360(4):907-20. PubMed ID: 16782127
[TBL] [Abstract][Full Text] [Related]
19. The 118-135 peptide of the human prion protein forms amyloid fibrils and induces liposome fusion.
Pillot T; Lins L; Goethals M; Vanloo B; Baert J; Vandekerckhove J; Rosseneu M; Brasseur R
J Mol Biol; 1997 Dec; 274(3):381-93. PubMed ID: 9405147
[TBL] [Abstract][Full Text] [Related]
20. Conformational properties of peptide fragments homologous to the 106-114 and 106-126 residues of the human prion protein: a CD and NMR spectroscopic study.
Di Natale G; Impellizzeri G; Pappalardo G
Org Biomol Chem; 2005 Feb; 3(3):490-7. PubMed ID: 15678187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]